SIREN : 793010216
PHARMACIE BILLOD is a French company founded 13 years ago, specialized in the sector Gestion de fonds. Based in PUISSERGUIER (34620), this company of category PME shows in 2020 a revenue of 1.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | 1 014 143 € | N/C | N/C | N/C | N/C |
| Net income | 129 208 € | 112 011 € | 134 550 € | 108 446 € | 136 905 € | 83 395 € | 99 701 € | 85 992 € | 134 254 € |
| EBITDA | N/C | N/C | N/C | N/C | 137 539 € | N/C | N/C | N/C | N/C |
| Net margin | N/C | N/C | N/C | N/C | 13.5% | N/C | N/C | N/C | N/C |
In 2024, PHARMACIE BILLOD generates positive net income of 129 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 134 k€ -> 129 k€.
129 208 €
The debt ratio (= Financial debt / Equity x 100) stands at 22%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 72%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
21.954%
71.577%
29.9%
In 2024, the debt ratio of PHARMACIE BILLOD (21.95) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of PHARMACIE BILLOD (71.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
The liquidity ratio (= Current assets / Current liabilities) stands at 497.21. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
497.213
In 2024, the liquidity ratio of PHARMACIE BILLOD (497.21) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 62 transactions of similar company sales
in 2024,
the value of PHARMACIE BILLOD is estimated at
955 009 €
(range 271 152€ - 1 891 975€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare PHARMACIE BILLOD with other companies in the same sector:
The revenue of PHARMACIE BILLOD in 2020 is 1.0 M€.
Yes, PHARMACIE BILLOD generated a net profit of 129 k€ in 2024.
The headquarters of PHARMACIE BILLOD is located in PUISSERGUIER (34620), in the department Herault.
The tax return of PHARMACIE BILLOD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
PHARMACIE BILLOD operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.